Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
ChenGuang Biotech Group Co., Ltd. (300138.SZ)
Quzhou, CN
ChenGuang Biotech Group Co., Ltd. is a key player in the development and production of natural ingredients. Its extensive product catalog encompasses natural colorants, including paprika and marigold oleoresins, as well as turmeric. The company also manufactures a diverse array of spice extracts and essential oils, such as capsicum oleoresin, Sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oil. Furthermore, ChenGuang Biotech provides a variety of nutritional and pharmaceutical extracts like lutein, lycopene, grape seed extract, curcumin, inulin, stevioside, and green coffee bean extracts. Rounding out its offerings are various oils and protein products, specifically grape seed, walnut, safflower, flaxseed, and cottonseed oils, alongside natural lutein and dephenolized cottonseed protein. These versatile ingredients are widely utilized across sectors such as food, beverages, cosmetics, baking, healthcare, and animal feed. Established in 2000 and based in Quzhou, China, the company has a global operational footprint, serving customers across Europe, the Americas, Australia, Asia (including China, Russia, Japan, and Korea), and Africa.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.94% | -0.28% | -8.76% | -27.40% | -15.77% | -15.23% | -6.16% | -42.23% | -28.19% | +32.83% | +32.83% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | +1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Farm Products: +8.2%-6.2% Q1'26: -5.1% (vs Q1'25)
-
EPS growth Agricultural Farm Products: +20.0%+322.2% ★ Q1'26: -13.0% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Farm Products: +43.8%-1.6% Q1'26: +15.4% (vs Q1'25)
-
EBIT margin Agricultural Farm Products: +8.1%+6.7% Q1'26: +8.8% (vs Q1'25)
-
ROIC Agricultural Farm Products: +6.0%+6.2% ★ Q1'26: +7.3% (vs Q1'25)
-
Share dilution Agricultural Farm Products: +0.0%-8.0% ★ Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Farm Products: 0.61×6.86× Q1'26: 11.66× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 3 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.27B
est: 1.27B (0.0%)
|
2.14B
est: 2.14B (0.0%)
|
2.77B
est: 3.01B (-7.8%)
|
3.74B
est.
|
3.06B
est: 4.98B (-38.5%)
|
3.27B
est: 4.98B (-34.4%)
|
3.86B
est.
|
4.87B
est: 4.79B (+1.7%)
|
3.91B
est: 4.79B (-18.4%)
|
6.30B
est: 6.30B (0.0%)
|
6.87B
est: 6.69B (+2.7%)
|
6.99B
est: 7.09B (-1.4%)
|
6.56B
est: 6.99B (-6.2%)
|
6.93B
6.84B – 7.02B
-0.9% YoY
|
7.53B
7.34B – 7.71B
+8.6% YoY
|
8.28B
8.24B – 8.33B
+10.1% YoY
|
| EBITDA |
142.23M
est: 133.38M (+6.6%)
|
179.59M
est: 225.21M (-20.3%)
|
233.01M
est: 316.40M (-26.4%)
|
393.66M
est.
|
275.67M
est: 523.57M (-47.3%)
|
365.81M
est: 523.57M (-30.1%)
|
406.02M
est.
|
583.05M
est: 504.21M (+15.6%)
|
504.22M
est: 504.21M (+0.0%)
|
715.23M
est: 662.28M (+8.0%)
|
791.87M
est: 665.19M (+19.0%)
|
391.54M
est: 705.03M (-44.5%)
|
606.63M
est: 695.05M (-12.7%)
|
688.65M
679.99M – 697.30M
-0.9% YoY
|
747.81M
729.90M – 765.71M
+8.6% YoY
|
823.27M
819.00M – 827.54M
+10.1% YoY
|
| EBIT |
95.28M
est: 101.75M (-6.4%)
|
129.95M
est: 171.80M (-24.4%)
|
175.89M
est: 241.37M (-27.1%)
|
300.31M
est.
|
199.37M
est: 399.41M (-50.1%)
|
277.01M
est: 399.41M (-30.6%)
|
309.74M
est.
|
452.43M
est: 384.64M (+17.6%)
|
391.93M
est: 384.64M (+1.9%)
|
570.66M
est: 505.22M (+13.0%)
|
639.33M
est: 503.14M (+27.1%)
|
225.32M
est: 533.27M (-57.7%)
|
440.42M
est: 525.72M (-16.2%)
|
520.88M
514.33M – 527.42M
-0.9% YoY
|
565.62M
552.08M – 579.17M
+8.6% YoY
|
622.70M
619.47M – 625.93M
+10.1% YoY
|
| Net Income |
68.86M
est: 83.58M (-17.6%)
|
92.47M
est: 100.30M (-7.8%)
|
142.83M
est: 140.42M (+1.7%)
|
289.70M
est.
|
145.28M
est: 201.76M (-28.0%)
|
193.57M
est: 201.76M (-4.1%)
|
256.94M
est.
|
351.51M
est: 331.37M (+6.1%)
|
267.74M
est: 331.37M (-19.2%)
|
434.03M
est: 419.03M (+3.6%)
|
479.72M
est: 258.47M (+85.6%)
|
94.05M
est: 89.55M (+5.0%)
|
368.87M
est: 379.34M (-2.8%)
|
423.22M
408.00M – 438.44M
+11.6% YoY
|
532.52M
508.86M – 548.48M
+25.8% YoY
|
603.64M
601.20M – 659.13M
+13.4% YoY
|
| SGA |
99.66M
est: 19.67M (+406.8%)
|
189.51M
est: 33.20M (+470.7%)
|
152.19M
est: 46.65M (+226.2%)
|
58.04M
est.
|
217.26M
est: 77.19M (+181.4%)
|
268.14M
est: 77.19M (+247.4%)
|
59.86M
est.
|
210.35M
est: 74.34M (+183.0%)
|
191.71M
est: 74.34M (+157.9%)
|
249.21M
est: 97.64M (+155.2%)
|
212.03M
est: 206.11M (+2.9%)
|
207.23M
est: 218.46M (-5.1%)
|
70.43M
est: 215.36M (-67.3%)
|
213.38M
210.70M – 216.06M
-0.9% YoY
|
231.71M
226.16M – 237.26M
+8.6% YoY
|
255.09M
253.77M – 256.42M
+10.1% YoY
|
| EPS |
0.16
est: 0.16 (-1.0%)
|
0.18
est: 0.19 (-7.2%)
|
0.28
est: 0.27 (+3.2%)
|
0.56
est.
|
0.28
est: 0.39 (-28.2%)
|
0.38
est: 0.39 (-2.6%)
|
0.50
est.
|
0.67
est: 0.64 (+4.6%)
|
0.55
est: 0.64 (-14.1%)
|
0.81
est: 0.81 (+0.0%)
|
0.90
est: 0.54 (+65.7%)
|
0.18
est: 0.19 (-4.3%)
|
0.76
est: 0.80 (-4.7%)
|
0.89
0.86 – 0.92
+11.6% YoY
|
1.11
1.07 – 1.15
+24.9% YoY
|
1.32
1.26 – 1.38
+19.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-28 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-27 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-26 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-25 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-22 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-21 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-19 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-18 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-15 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-14 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-13 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-12 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 42.6K | 0.46% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 99.0K | 0.39% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 72.1K | 0.29% |
| 4 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 35.7K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Feng Fei Li | Deputy General Manager | — | male |
| Jing Zhou | Chief Financial Officer, Secretary of the Board & Director | — | female |
| Qingguo Lu | Chairman & GM | — | male |
| Wei Gao | Deputy General Manager | — | male |
| Yun He Lian | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300138.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
